**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 606-55-3 |Quinolinium, 1-ethyl-2-methyl-, iodide| 97% | 210-120-7 |
| | | | |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: XI
Risk Phrases: 36/37/38
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Irritating to eyes, respiratory system and skin.Moisture
sensitive.The toxicological properties of this material have not been
fully investigated.
Potential Health Effects
Eye:
Causes eye irritation.
Skin:
Causes skin irritation.
Ingestion:
May cause irritation of the digestive tract.
Inhalation:
Causes respiratory tract irritation.
Chronic:
No information found.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Immediately flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid
immediately.
Skin:
Get medical aid. Immediately flush skin with plenty of water for at
least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Do not induce vomiting. If victim is conscious and alert, give 2-4
cupfuls of milk or water. Never give anything by mouth to an
unconscious person. Get medical aid immediately.
Inhalation:
Remove from exposure and move to fresh air immediately. If not
breathing, give artificial respiration. If breathing is difficult,
give oxygen. Get medical aid.
Notes to Physician:
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or appropriate foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Clean up spills immediately, observing precautions in the Protective
Equipment section. Sweep up, then place into a suitable container for
disposal. Avoid generating dusty conditions.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Use with adequate ventilation. Avoid
contact with skin and eyes. Avoid ingestion and inhalation.
Storage:
Store in a cool, dry place. Keep container closed when not in use.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Use adequate ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 606-55-3:
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
Follow the OSHA respirator regulations found in 29
CFR 1910.134 or European Standard EN 149. Use a
NIOSH/MSHA or European Standard EN 149 approved
respirator if exposure limits are exceeded or if
irritation or other symptoms are experienced.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Powder
Color: yellow
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 244 deg C (dec)
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C12H14IN
Molecular Weight: 299.14
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, moisture.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, irritating and toxic fumes and
gases, carbon dioxide, hydrogen iodide, iodide ions (I-).
Hazardous Polymerization: Has not been reported
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 606-55-3: VA0740000
LD50/LC50:
Not available.
Carcinogenicity:
Quinolinium, 1-ethyl-2-methyl-, iodide -
Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XI
Risk Phrases:
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 36/37/39 Wear suitable protective clothing, gloves
and eye/face protection.
WGK (Water Danger/Protection)
CAS# 606-55-3: No information available.
Canada
CAS# 606-55-3 is listed on Canada's DSL List.
CAS# 606-55-3 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 606-55-3 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 3/04/1998 Revision #2 Date: 3/18/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
Monomethyl monopotassiummalonate, 98%
| 38330-80-2 |
|
4-Bromomandelic Acid, 96% (HPLC)
| 6940-50-7 |
|
Stigmasterol, 95%
| 83-48-7 |
|
2-Chloro-6-Nitrotoluene, 99%
| 83-42-1 |
|
[Tris(trimethylsilyl)]arsenide, 98%
| 17729-30-5 |
|
1-Ethylquinaldinium Iodide, 97% (titr.)
| 606-55-3 |
|
L-Aspartyl-L-Phenylalanine Methyl Ester, 98%
| 22839-47-0 |
|
Primaquine diphosphate, 99+%
| 63-45-6 |
|
Ethyl 5-Hydroxy-2-Methylindole-3- Carboxylate
| 7598-91-6 |
|
(R)-(-)-1-Amino-2-Propanol, 98+%
| 2799-16-8 |
|
N-Methylthiourea, 97%
| 598-52-7 |
|
2,3,4,5,6-Pentafluoroanisole, 97+%
| 389-40-2 |
|
Cyclohexene Oxide, 98%
| 286-20-4 |
|
5-beta-Pregnane-3-alpha,20-alpha-diol, 99%
| 80-92-2 |
|
Cyclooctene Oxide, 99%
| 286-62-4 |
|
2-(4-Methoxyphenyl)-4,6-Diphenylpyrylium Tetrafluoroborate
| 2907-13-3 |
|
Sodium Hexafluoroantimonate, 98% (Titr.)
| 16925-25-0 |
|
Ethylene/Acrylic Acid Copolymer
| 9010-77-9 |
|
4-Fluoro-2-Nitrotoluene, 98%
| 446-10-6 |
|
N-Carbethoxy-4-Piperidone, 97+%
| 29976-53-2 |
|
3-Methylhippuric acid,98+%
| 27115-49-7 |
|
Amberlite cg-400 ion-exchange resin
| 37247-87-3 |
|
3-Nitrotoluene, 99%
| 99-08-1 |
|
1,3-Diphenylguanidine, 99% (uv-vis)
| 102-06-7 |
|
2-Bromo-4-Methylaniline, 98%
| 583-68-6 |
|
2,2'-Bithiophene
| 492-97-7 |
|
5,6-Dimethylbenzimidazole, 99+%
| 582-60-5 |
|
4-Butoxyaniline, 99% (titr.)
| 4344-55-2 |
|
Alpha-Cyano-O-Tolunitrile, Tech.
| 3759-28-2 |
|
DL-Laudanosoline Hydrobromide Trihydrate, 98%
| 485-33-6 |
|
4-Chloro-6-Nitro-Meta-Cresol, 99%
| 7147-89-9 |
|
2-Butanone oxime, 99%
| 96-29-7 |
|
Hexachloropropene, 96%
| 1888-71-7 |
|
Isopropyl Chloroacetate, 99%
| 105-48-6 |
|
3-Methylpentane, 99+%
| 96-14-0 |
|
1,4-Cyclohexanedicarboxylic Acid, 96% (Titr.)
| 1076-97-7 |
|
Azoxybenzene, 97%
| 495-48-7 |
|
l-(+)-Lactic acid, lithium salt
| 27848-80-2 |
|
4-Hexylresorcinol, 99%
| 136-77-6 |
|
Tantalum (V) Chloride, 99.9%
| 7721-01-9 |
|
2,4,5-Trimethylthiazole, 99%
| 13623-11-5 |
|
Cycloheptane, 99%
| 291-64-5 |
|
Phenylglyoxal monohydrate, 97%
| 1074-12-0 |
|
Ethyl Carbazate, 97%
| 4114-31-2 |
|
bis(Methylthio)methane, 99+%
| 1618-26-4 |
|
1-Bromo-4-Tert-Butylbenzene, 97+%
| 3972-65-4 |
|
(S)-(+)-2-Amino-2-methylbutanoic acid monohydrate, 99+% (>99% e.e.)
| 0-00-0 |
|
2-Furonitrile, 99%
| 617-90-3 |
|
l-Adrenaline, 97% (titr.)
| 51-43-4 |
|
4-(3-Methyl-5-oxo-2-pyrazolin-1-yl)benzoic acid, 98+%
| 60875-16-3 |
|
|